Tu1298 Anti-Infliximab Antibodies With Neutralizing Capacity in Inflammatory Bowel Disease Patients: Distinct Clinical Implications Revealed by a Novel Assay
Saved in:
| Published in: | Gastroenterology (New York, N.Y. 1943) Vol. 148; no. 4; pp. S-851 - S-852 |
|---|---|
| Main Authors: | , , , , , , , |
| Format: | Journal Article |
| Language: | English |
| Published: |
Elsevier Inc
01-04-2015
|
| Subjects: | |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Author | Ben-Horin, Shomron Weisshof, Roni Chowers, Yehuda Dahan, Aviva Blatt, Alexandra Ungar, Bella Kopylov, Uri Waterman, Matti |
|---|---|
| Author_xml | – sequence: 1 fullname: Weisshof, Roni – sequence: 2 fullname: Ungar, Bella – sequence: 3 fullname: Blatt, Alexandra – sequence: 4 fullname: Dahan, Aviva – sequence: 5 fullname: Waterman, Matti – sequence: 6 fullname: Kopylov, Uri – sequence: 7 fullname: Ben-Horin, Shomron – sequence: 8 fullname: Chowers, Yehuda |
| BookMark | eNqFkMtuEzEUhi3USqQtj4DkJSwGfJHnwgIUQoFIVUFQxNLyeI7hlIkd2U7o8C68K56kYsGGjY997P-Tz3dGTnzwQMhjzp5xxuvnn1lZK8Va9YSrp1K0bV11D8iCK9FW5U6ckMXfJw_JWUq3jLFOtnxBft_suOhauvQZq7V3I97hxvSHcx8GhES_Yv5Or2GXoxnxF_pvdGW2xmKeKHo6Z8xmY3KIE30dfsJI32ACk4B-NBnB5_Ri7mT0NtPViB6tGel6sx3LJmPwiX6CPZgRBtpP1NDrsC-QZUpmuiCnzowJHt3Xc_Ll7eXN6n119eHderW8qixXTVcNVg5CdT03TDCnGi6YEU0roVGshraprVIgnVSgmJCuretucKIZemmdNdbJc6KOXBtDShGc3saiIU6aMz071gfHehaoudIHx7oruVfHHJTP7RGiTraMbGHACDbrIeB_CS__Idh7RT9ggnQbdtGXyTXXSWh2hMwMrg6ETv4BwGacPA |
| ContentType | Journal Article |
| Copyright | AGA Institute 2015 AGA Institute |
| Copyright_xml | – notice: AGA Institute – notice: 2015 AGA Institute |
| DBID | AAYXX CITATION |
| DOI | 10.1016/S0016-5085(15)32886-9 |
| DatabaseName | CrossRef |
| DatabaseTitle | CrossRef |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1528-0012 |
| EndPage | S-852 |
| ExternalDocumentID | 10_1016_S0016_5085_15_32886_9 S0016508515328869 1_s2_0_S0016508515328869 |
| GroupedDBID | --- --K .1- .55 .FO .GJ 0R~ 1B1 1CY 1P~ 1~5 3O- 4.4 457 4G. 53G 5GY 5RE 5VS 7-5 AAEDT AAEDW AAIKJ AALRI AAQFI AAQOH AAQQT AAQXK AAXUO AAYOK ABCQX ABJNI ABLJU ABMAC ABOCM ADBBV ADMUD ADPAM AENEX AEVXI AFCTW AFFNX AFHKK AFJKZ AFRHN AFTJW AGHFR AI. AITUG AJUYK ALMA_UNASSIGNED_HOLDINGS AMRAJ ASPBG AVWKF AZFZN BELOY BR6 C5W CAG COF CS3 DU5 EBS EFJIC EJD F5P FD8 FDB FEDTE FGOYB G8K GBLVA HVGLF HZ~ IHE J1W J5H K-O KOM L7B M41 MO0 N4W N9A NQ- O9- OC. OHT ON0 P2P PC. QTD R2- RIG ROL RPZ SEL SES SJN SSZ TWZ UDS UGJ UV1 VH1 WH7 X7M XH2 Y6R YQJ Z5R ZGI ZXP AAIAV AGZHU AHPSJ ALXNB ZA5 AAYXX ABDPE CITATION |
| ID | FETCH-LOGICAL-c1579-dc3d259b1a020f57120a2783e7506e876c55e3f35e5023f8669df27db3cfcacf3 |
| ISSN | 0016-5085 |
| IngestDate | Fri Nov 22 00:33:51 EST 2024 Fri Feb 23 02:19:47 EST 2024 Tue Oct 15 14:34:09 EDT 2024 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 4 |
| Language | English |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-c1579-dc3d259b1a020f57120a2783e7506e876c55e3f35e5023f8669df27db3cfcacf3 |
| ParticipantIDs | crossref_primary_10_1016_S0016_5085_15_32886_9 elsevier_sciencedirect_doi_10_1016_S0016_5085_15_32886_9 elsevier_clinicalkeyesjournals_1_s2_0_S0016508515328869 |
| PublicationCentury | 2000 |
| PublicationDate | April 2015 |
| PublicationDateYYYYMMDD | 2015-04-01 |
| PublicationDate_xml | – month: 04 year: 2015 text: April 2015 |
| PublicationDecade | 2010 |
| PublicationTitle | Gastroenterology (New York, N.Y. 1943) |
| PublicationYear | 2015 |
| Publisher | Elsevier Inc |
| Publisher_xml | – name: Elsevier Inc |
| SSID | ssj0009381 |
| Score | 2.1929858 |
| SourceID | crossref elsevier |
| SourceType | Aggregation Database Publisher |
| StartPage | S-851 |
| SubjectTerms | Gastroenterology and Hepatology |
| Title | Tu1298 Anti-Infliximab Antibodies With Neutralizing Capacity in Inflammatory Bowel Disease Patients: Distinct Clinical Implications Revealed by a Novel Assay |
| URI | https://www.clinicalkey.es/playcontent/1-s2.0-S0016508515328869 https://dx.doi.org/10.1016/S0016-5085(15)32886-9 |
| Volume | 148 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Jb9NAFB41RUJcEKsIm-bAARRNie2MF24hDbRC9NC0AnGxxuNxY4naKE7C8l_4r7w3S-yWgACJyyieeBn5fX7bvIWQJ4AbqUDwMC8XaKDk8M3FYc6SKB9m2KRG6o32g1l09D7en46mOz3Xm7Od-6-UhjmgNWbO_gW1NzeFCfgNNIcRqA7jn9F9BbI1xqIAJTvElI8v5bnI9HFWY8ggMILlHJjbSvs4vul9f5CYEtXxEl2EBYDk3Gy-v6w_K2SLehMHy_mXOu4iGOPcsqzkcjBxqZWH3dj0Y7VGDVRrt2JwVK-VRoK4sIn8WjTLRY1FQRemEtSWzkADLxl1ncHvFCBlXhcmKrwq3fxpdWZCxTHhqHUyfBRm88vm8Sw2_-yLuXH9jtflWnR9Hx7vhMxYfu6FDFRMfoGfj-IOcEcd7jxjsa1uqzbH_lY5Ylwas839sWgWDKDsApJZ0gpPFzAwnbzxWOPvDZm-CK8BWYJnXzrZWF5p46fD9KdTe-SKDwwTe0B84Mdt8eggNp0f7WraTLTn7RKfevyZXd52HaujN53cINetwUPHBqk3yY6qbpGrb21Ix23y3QCWXgIsbQFLEbC0C1jqAEvLinYBSzVgqQUsdYB9QR1cqYMr7cKVOrjS7CsVVMOVarjeIaevpieTA2Z7hjDp8ShhuQxysOgzT4AdVPDI84cCm8ko0IxDBaJfcq6CIuCKAyMq4jBM8sKP8iyQhRSyCO6S3aqu1D1CwfIJgDBgInCQdCDoilAUMsv8WIVhzlWf7Lm3nH4ypWHSNmYSRyRL6vFUkyVN-iRytEhd3jNIatVY9tGkv8JFn8SbK61mbDTeFAD7-4fe_-eHPiDX2m_uIdldLlbqEek1-eqxhucPr7TSeg |
| link.rule.ids | 315,782,786,27934,27935 |
| linkProvider | Elsevier |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Tu1298+Anti-Infliximab+Antibodies+With+Neutralizing+Capacity+in+Inflammatory+Bowel+Disease+Patients%3A+Distinct+Clinical+Implications+Revealed+by+a+Novel+Assay&rft.jtitle=Gastroenterology+%28New+York%2C+N.Y.+1943%29&rft.au=Weisshof%2C+Roni&rft.au=Ungar%2C+Bella&rft.au=Blatt%2C+Alexandra&rft.au=Dahan%2C+Aviva&rft.date=2015-04-01&rft.issn=0016-5085&rft.volume=148&rft.issue=4&rft.spage=S-851&rft.epage=S-852&rft_id=info:doi/10.1016%2FS0016-5085%2815%2932886-9&rft.externalDBID=ECK1-s2.0-S0016508515328869&rft.externalDocID=1_s2_0_S0016508515328869 |
| thumbnail_m | http://sdu.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F00165085%2FS0016508515X6001X%2Fcov150h.gif |